Update from Developmental Medicine & Child Neurology – June 2024

Update from Developmental Medicine & Child Neurology – June 2024

17th June, 2024

Standardized Infant Neuro Developmental Assessment (SINDA)

Society discounts apply. *Simply enter society coupon code when ordering here*. Get in touch with admin@mackeith.co.uk if you have any questions.

Standardized Infant Neuro Developmental Assessment (SINDA) is a book that introduces a screening tool to detect infants at risk for neurodevelopmental disorders in the first year of life life.

In addition to thoroughly describing the elements of the screening examination with pictures in the book, there are over 100 videos to use as a reference. An essential resource for health professionals working in the field of early detection and early intervention, i.e., paediatricians, developmental paediatricians, neonatologists, child neurologists – available in paperback and eBook.

Buy Now

Look Inside
















DMCN June 2024 Issue

DMCN Editor’s Choice:

Circulating immune cell populations at rest and in response to acute endurance exercise in young adults with cerebral palsy

The aim of this observational study was to determine the immune status and function in young adults with cerebral palsy (CP) in comparison to typically developing individuals.

Key papers in Developmental Medicine & Child Neurology this month:

Strategies supporting parent-delivered rehabilitation exercises to improve motor function after paediatric traumatic brain injury: A systematic review

This study identifies and analyses ways in which parents are supported to deliver rehabilitation exercises to their child after traumatic brain injury (TBI), conceptualized as strategies.

State-of-the-art therapies for fragile X syndrome

Fragile X syndrome (FXS) is a neurodevelopmental disorder caused by a full mutation (> 200 CGG repeats) in the FMR1 gene. This paper adds that a targeted treatment of fragile X syndrome (FXS) is the best current therapeutic approach, and gene therapy holds potential as a prospective treatment for FXS in the future.

Check out the rest of the July 2024 issue here.

Visit Early View to see the most recent publications.

Top podcast

In this podcast, Rob Forsyth discusses his paper ‘Defining paediatric neurorehabilitation: You cannot improve what you cannot characterize’.

Read the paper